Research graph
References from Prognostic model of HIV-associated talaromycosis in south China: A large-scale retrospective study. Local targets link to admitted publications; unresolved targets remain external evidence.
An Overlooked and Underrated Endemic Mycosis-Talaromycosis and the Pathogenic Fungus Talaromyces marneffei
10.1128/cmr.00051-22 · 2023 · External reference
Analysis of clinical characteristics and prognosis of talaromycosis (with or without human immunodeficiency virus) from a non-endemic area: a retrospective study
10.1007/s15010-021-01679-6 · 2022 · External reference
Serological surveillance for Penicillium marneffei infection in HIV-infected patients during 2004-2011 in Guangzhou, China
10.1016/j.cmi.2014.12.014 · 2015 · External reference
Burden of Talaromyces marneffei infection in people living with HIV/AIDS in Asia during ART era: a systematic review and meta-analysis
10.1186/s12879-020-05260-8 · 2020 · External reference
A Trial of Itraconazole or Amphotericin B for HIV-Associated Talaromycosis
10.1056/nejmoa1613306 · 2017 · External reference
Effects of Talaromyces marneffei infection on mortality of HIV/AIDS patients in southern China: a retrospective cohort study
10.1016/j.cmi.2018.04.018 · 2019 · External reference
Clinical epidemiology and outcome of HIV-associated talaromycosis in Guangdong, China, during 2011-2017
10.1111/hiv.13024 · 2020 · External reference
Penicillium marneffei infection: an emerging disease in mainland China
10.1007/s11046-012-9577-0 · 2013 · External reference
Clinical Characteristics and Prognosis of Penicilliosis Among Human Immunodeficiency Virus-Infected Patients in Eastern China
10.4269/ajtmh.16-0521 · 2017 · External reference
Machine learning-based in-hospital mortality prediction of HIV/AIDS patients with Talaromyces marneffei infection in Guangxi, China
2022 · External reference
Aspartate Aminotransferase/Platelet Ratio Index Upon Admission Predicts 24-Week Mortality in Patients With HIV-Associated Talaromyces marneffei
10.1093/ofid/ofad593 · 2023 · External reference
Clinical features of HIV positive talaromycosis marneffei patients and development of a risk prediction model
2023 · External reference
Characteristics and risk factors for death in HIV-positive talaromycosis marneffei patients with sepsis
10.1016/j.heliyon.2024.e34024 · 2024 · External reference
Risk factors and prediction model for mortality in HIV/Talaromyces marneffei co-infection: A retrospective cohort study
10.1016/j.heliyon.2024.e32560 · 2024 · External reference
An evaluation of Mp1p antigen screening for talaromycosis in HIV-infected antiretroviral therapy-naïve population in Guangdong, China
10.1371/journal.pntd.0011785 · 2023 · External reference
Decision curve analysis: a novel method for evaluating prediction models
10.1177/0272989x06295361 · 2006 · External reference
Macrophages and the human immunodeficiency virus
10.1016/0167-5699(90)90086-o · 1990 · External reference
Talaromyces marneffei influences macrophage polarization and sterilization ability via the arginine metabolism pathway in vitro
10.4269/ajtmh.21-0568 · 2022 · External reference
Talaromyces marneffei Can Capture CD86 Proteins of Macrophages in vitro
10.2147/idr.s389612 · 2022 · External reference
Penicillium marneffei Infection in AIDS
2011 · External reference
Talaromyces marneffei activates the AIM2-caspase-1/-4-GSDMD axis to induce pyroptosis in hepatocytes
10.1080/21505594.2022.2080904 · 2022 · External reference
